Literature DB >> 20485164

Decolonization therapy in infection control.

Courtney Hebert1, Ari Robicsek.   

Abstract

PURPOSE OF REVIEW: Hospital acquired infections (HAIs) are costly and are a leading cause of hospital death. Many HAIs originate from patients' own flora. Decolonization strategies aim to prevent infection from these endogenous sources. This review focuses on data published from 2008 to the present on effectiveness and safety of patient decolonization strategies for preventing HAIs. RECENT
FINDINGS: Surgical site infections (SSIs): recent literature confirms that Staphylococcus aureus decolonization to prevent SSIs is effective in cardiac and likely certain orthopedic surgery patients. The benefit to general surgery patients is not clear. Ventilator-associated pneumonia (VAP): although past studies have found that decolonization benefits cardiac surgery patients, recent studies have not found the same benefit in general medical and surgical ICU patients. Blood stream infection (BSI): mupirocin on hemodialysis catheter exit sites is protective against BSI. Chlorhexidine and selective decontamination of the digestive tract have been studied as ways to decrease ICU BSI, but their roles are still being clarified. Methicillin-resistant Staphylococcus aureus (MRSA)-specific decolonization: evidence of benefit to MRSA-colonized nonsurgical patients is lacking.
SUMMARY: Decolonization is likely an effective infection-control strategy for hemodialysis catheter-associated infections and in cardiac and orthopedic surgery patients. More research is needed on its role in other settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20485164     DOI: 10.1097/QCO.0b013e32833ae214

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  7 in total

Review 1.  Antibacterial Prophylaxis for Surgical Site Infection in the Elderly: Practical Application.

Authors:  Maria Adriana Cataldo; Guido Granata; Nicola Petrosillo
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

2.  An N-halamine-based rechargeable antimicrobial and biofilm controlling polyurethane.

Authors:  Xinbo Sun; Zhengbing Cao; Nuala Porteous; Yuyu Sun
Journal:  Acta Biomater       Date:  2011-12-27       Impact factor: 8.947

3.  A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation.

Authors:  George A Yendewa; J McLeod Griffiss; Michael R Jacobs; Scott A Fulton; Mary Ann O'Riordan; Wesley A Gray; Howard M Proskin; Peter Winkle; Robert A Salata
Journal:  J Glob Antimicrob Resist       Date:  2019-10-07       Impact factor: 4.035

4.  2019 EACTS Expert Consensus on long-term mechanical circulatory support.

Authors:  Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson
Journal:  Eur J Cardiothorac Surg       Date:  2019-08-01       Impact factor: 4.191

5.  Persistent nasal methicillin-resistant staphylococcus aureus carriage in hemodialysis outpatients: a predictor of worse outcome.

Authors:  Holger Schmid; Andre Romanos; Helmut Schiffl; Stephan R Lederer
Journal:  BMC Nephrol       Date:  2013-04-23       Impact factor: 2.388

6.  Decolonization of patients and health care workers to control nosocomial spread of methicillin-resistant Staphylococcus aureus: a simulation study.

Authors:  Tatiana V Gurieva; Martin C J Bootsma; Marc J M Bonten
Journal:  BMC Infect Dis       Date:  2012-11-14       Impact factor: 3.090

7.  Staphylococcus aureus and repeat bacteremia in febrile patients as early signs of sternal wound infection after cardiac surgery.

Authors:  Teruya Nakamura; Takashi Daimon; Norio Mouri; Hirotada Masuda; Yoshiki Sawa
Journal:  J Cardiothorac Surg       Date:  2014-05-08       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.